Skip to main content
Sister Publication Links
  • ModernHealthcare.com
Subscribe
  • My Account
  • Login
  • Register
  • Consumer Centric
  • Provider/Payer Centric
  • Funding/M&A
  • Policy
  • Data
  • Opinion
  • MORE+
    • Webinars
    • Advertise
MENU
Breadcrumb
  1. Home
  2. Mergers & Acquisitions (M&A)
January 20, 2022 06:19 PM

Digital therapeutics company DarioHealth buying Physimax

Michael Brady
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    deal-making-merger.png
    Modern Healthcare Illustration / Getty Images

    DarioHealth, a digital therapeutics company specializing in chronic conditions, is buying Physimax Technologies Ltd., a startup that uses artificial intelligence to carry out musculoskeletal functional screening and predict injury risk, according to a news release Thursday.

    The company will issue up to 256,660 shares of common stock and pay $500,000 in cash to acquire Physimax. DarioHealth will also assume more than $1 million in liabilities from Physimax as part of the deal.

    "We are committed to bringing cutting-edge technologies to our suite of offerings to enhance the user experience and improve outcomes. We believe that Physimax's technology strengthens our ability to scale highly effective treatments for musculoskeletal health and reduce the burden on Dario professional human support. Physimax's technology supports rapid growth of membership without the traditional limitations of MSK care delivered by humans," said DarioHealth CEO Erez Raphael said in a news release.

    The latest acquisition could help DarioHealth accomplish its goal of becoming a one-stop shop for digital therapeutics to manage chronic conditions like hypertension, diabetes and musculoskeletal disorders.

    Providers, health plans and employers are increasingly looking to partner with companies that can offer integrated solutions to lower healthcare costs, boost outcomes and improve the patient experience. While single-point solutions can often help address an issue, they can also worsen the existing fragmentation in the healthcare delivery system.

    Venture capitalists invested almost $31 billion in digital health in 2021, according to data from Digital Health Business & Technology. That's more than double the nearly $15 million raised in 2020.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it online.

    Recommended for You
    bayer
    Digital health funding and deals roundup: Bayer acquires AI platform company
    Screen Shot 2021-11-09 at 8.37.49 PM.png
    GE HealthCare makes first acquisition as independent company
    Sponsored Content
    Get Newsletters

    Newsletters for providers, payers, investors and innovators across the digital health ecosystem. Sign up to get breaking digital health news including digital health deals, M&A, finance, IPOs. as they happen, right to your inbox.

    Buy Q3 Report Today
    Quarterly Report Cover Image

    The Digital Health Funding and M&A Q3 report delivers the most comprehensive insight and data around the financial health of the sector.

    Purchase Today
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Digital Health Business & Technology delivers news, data, insights and analysis covering the entire digital healthcare ecosystem.

    Logo
    Contact Us

    (877) 812-1581

    Email us

     

    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    Resources
    • About Us
    • Contact Us
    • Staff
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Digital Health Business & Technology
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • Consumer Centric
    • Provider/Payer Centric
    • Funding/M&A
    • Policy
    • Data
    • Opinion
    • MORE+
      • Webinars
      • Advertise